Company: HCTI
Filing Date: 2025-05-09
Form Type: S-1/A
Source: 0001213900-25-041190
Chunk: 3

Company: Healthcare Triangle, Inc.
Filing Date: 2025-05-09
Form: S-1/A
Chunk 3
---
 Adjustment Period is lower than the initial exercise price. If a reset of the exercise
price of a Purchase Warrant occurs, the number of shares of Common Stock underlying such Purchase Warrant will also be increased on the
trading day after the Adjustment Period End Date (the “Adjustment Date”), so that the reset exercise price multiplied by
increased number of shares equal the aggregate proceeds that would have resulted from the full exercise of such Purchase Warrant immediately
prior to the Adjustment Date. In addition, a holder of Series B Warrants may, at any time and in its sole discretion, exercise its Series
B Warrants in whole or in part by means of a “zero exercise price” option in which the holder is entitled to receive a number
of shares of Common Stock that shall equal the product of (x) the aggregate number of shares of Common Stock that would be issuable upon
exercise of the Series B Warrant in accordance with its terms if such exercise were by means of a cash exercise rather than through the
zero exercise price option and (y) 3. As a result of this feature, we do not expect to receive any cash proceeds from the exercise of
the Series B Warrants because it is highly unlikely that a Series B Warrant holder will elect to pay an exercise price in cash to receive
one share of common stock when they could elect the zero exercise price option in these circumstances to receive more shares of common
stock than they would receive if they did pay an exercise price. As an example, given the above provisions, holders of the Series B Warrants
will be issued a maximum of 1,085,714,550 shares of Common Stock upon the exercise of the Series B Warrants. Each Series B Warrant includes
one underlying share of common stock that may be obtained by exercising the Series B Warrant at an exercise price of $0.84; however if
the holder elects the zero exercise price option, the number of shares of common stock could increase to up to 30 shares of common stock
underlying each Series B Warrant if the exercise price decreases to and equals the Floor Price at the time of such election. As such,
holders of the Series B Warrants may elect to be issued up to 1,085,714,550 shares of common stock upon the exercise of the Series B
Warrants assuming the Floor Price. For a description of the risks involved with exercise of the Series B Warrants, see “Risk Factors—Risks
Related